Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
Submitted by
admin
on June 29, 2015 - 10:58am
Source:
Fierce Biotech
News Tags:
Merck
CINV
Emend
chemotherapy-induced nausea and vomiting
Headline:
Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
Do Not Allow Advertisers to Use My Personal information
